Two cases of traumatic wounds in patients with Ehlers-Danlos syndrome successfully treated with a bioengineered skin equivalent

Wounds

Volumn 15, Issue 6, 2003, Pages 201-207

  Abai, Babak ^a   Thayer, Dena ^a   Glat, Paul M ^a  

^a ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; BIOENGINEERING; CASE REPORT; CLINICAL FEATURE; COLLAGEN METABOLISM; DEBRIDEMENT; DISEASE ACTIVITY; DONOR SITE; EHLERS DANLOS SYNDROME; FEMALE; HUMAN; INJURY; MALE; METABOLIC DISORDER; MORBIDITY; PATIENT; PHYSICAL EXAMINATION; SCAR FORMATION; SCHOOL CHILD; SKIN GRAFT; TREATMENT OUTCOME; WOUND; WOUND DRESSING; WOUND HEALING;

EID: 0037772543     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Prockop D, Kuivaniemi H, Tromp G. Heritable disorders of connective tissue. In: Isselbacher K, Braunwald E, Wilson J, et al. (eds). Harrison's Principles of Internal Medicine, Thirteenth Edition. New York, NY: McGraw-Hill, 1994:2105-17.
2. Pyeritz R. Ehlers- Danlos syndrome. N Engl J Med 2000;342(10):730-2.
3. Maltz SB, Fantus RJ, Mellett MM, et al. Surgical complications of Ehlers-Danlos syndrome type IV. J Trauma 2001;51(2):387-90.
4. Lindgren VV, Hollister DW, Marshall WR. Wound healing and unsatisfactory scars. Plast Reconst Surg 1987;80(2):321-2.
5. Zarem H, Lowe N. Benign growths and generalized skin disorders. In: Aston S, Beasley R, Thorne C (eds). Grabb and Smith's Plastic Surgery, Fifth Edition. Philadelphia, PA: Raven-Lippencott, 1997:141-59.
6. Freeman RK, Swegle J, Sise MJ. The surgical complications of Ehlers-Danlos syndrome. Am Surg 1996;62:869-73.
7. Atillasoy E. Current and investigative uses of Graftskin (Apligraf) in wound care. WOUNDS 2000;12(5 Suppl A):3A.
8. Schmid P. Immunuhistologic characterization of Graftskin (Apligraf). WOUNDS 2000;12(5 Suppl A):4A-11A.
9. Ehlers E. Cutis laxa, neigung zu haemorrhagien in der haut, lockerung mehrerer artikulationen. Derm Zschr [Denmark] 1901;8:173-5.
10. Danlos M. Un cas de cutis laxa avec tumeurs par contusion chronique des coudes et des genoux. Bull Soc Franc Dermatol Syphiligr [France] 1908;19:70-2.
11. Beighton P. The Ehlers-Danlos syndromes. In: Beighton P. Mckusick's Heritable Disorders of Connective Tissue, Fifth Edition. St. Louis, MO: Mosby, 1993:189-251.
12. Beighton P. The Ehlers-Danlos Syndrome. London, England: Heinemann Medical, 1970:15-42, 109.
13. Ablaza VJ, Berlet AC, Manstein ME. An alternative treatment for the split skin-graft donor site. Aesth Plast Surg 1997;21:207-9.
14. Bell E, Ehrlich HP, Buttle DJ, et al. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 1981;211:1052-4.
15. Eaglstein WH, Falanga V. Tissue engineering for skin: An update. J Am Acad Dermatol 1998;39(6):1007-10.
16. Milstone LM, Asgari MM, Schwartz PM, et al. Growth factor expression, healing, and structural characteristics of Graftskin (Apligraf). WOUNDS 2000;12(5 Suppl A):12A-19A.
17. Atillasoy E. The safety and efficacy of Graftskin (Apligraf) in the treatment of venous leg ulcers: A multicenter, randomized, controlled clinical trial. WOUNDS 2000;12(5 Supp1 A):20A-26A.
18. Falanga V, Margolis D, Alvarez O, et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogenic cultured human skin equivalent. Arch Dermatol 1998;134:293-300.
19. McGinnis T. Significant FDA approvals in 2000. Am Fam Phys 2001;63(10).
20. Sabolinski ML, Veves A. Graftskin (Apligraf) in neuropathic diabetic foot ulcers. WOUNDS 2000;12(5 Suppl A):33A-36A.
21. Eaglstein WH, Iriondo M, Laszlo K. A Composite skin substitute (Graftskin) for surgical wounds. Dermatol Surg 1995;21:839-43.
22. Waymack P, Duff RG, Sabolinski M. The effect of a tissue engineered bilayered living skin analog over meshed split-thickness autografts on the healing of excised burn wounds. Burns 2000;26:609-19.
23. Still JM, Craft-Coffman B. Graftskin (Apligraf) in the management of thermal injury. WOUNDS 2000;12(5 Suppl A):58A-63A.
24. Falabella A, Valencia I, Eaglstein W, et al. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullossa wounds. Arch Dermatol 1999;135:1219-22.
25. Streit M, Bohlen LM, Braathen LR. Ulcerative sarcoidosis successfully treated with Apligraf. Dermatology 2001;202:367-70.